We are delighted to announce that Illingworth Research Group will be exhibiting at the 7th World Orphan Drug Congress on 19th – 21th April 2017, an event designed to bring together the stakeholders and pioneers of orphan drug development. This year’s venue is the near century old Marriot Wardman Park Hotel in the heart of Washington DC, USA.
The Congress is an important event in the Illingworth Research calendar, which allows us to meet with delegates and showcase our full capability CRO services, which could transform your multi-centre global studies, delivering it on time and within budget. Our clinical infrastructure covers most therapeutic areas varying from clinical research units, primary, secondary and tertiary care sites across Europe and we have partners in North America & Australasia. We also have some unique in-house services which many providers cannot match:
Research Nursing providing both on-site & within a homecare / workplace setting:
- Proven major impacts on patient recruitment & retention rates
- Assistance at investigator sites in completion of their own & sponsor’s projects therefore optimising the return on investigator site investment
- Enabling robust, reproducible & absolute quantification of endpoint data for dermal / sub-dermal indications through to illustrative & marketing images to accompany a study or compound portfolio.
If you are interested in pre-arranging a meeting at the event please get in touch, directly by calling Helen Springford or Julian Cooper on +44 1625 617447 or email Helen.Springford@illingworthresearch.com or Julian.Cooper@illingworthresearch.com